| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.37 | 3e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.27 | 1e-06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |